These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 15068406

  • 1. Spironolactone use in patients with heart failure.
    Trujillo JM, Gonyeau MJ, DiVall MV, Alexander SL.
    J Clin Pharm Ther; 2004 Apr; 29(2):165-70. PubMed ID: 15068406
    [Abstract] [Full Text] [Related]

  • 2. Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure.
    Lenzen MJ, Boersma E, Reimer WJ, Balk AH, Komajda M, Swedberg K, Follath F, Jimenez-Navarro M, Simoons ML, Cleland JG.
    Eur Heart J; 2005 Dec; 26(24):2706-13. PubMed ID: 16183692
    [Abstract] [Full Text] [Related]

  • 3. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.
    Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J.
    N Engl J Med; 1999 Sep 02; 341(10):709-17. PubMed ID: 10471456
    [Abstract] [Full Text] [Related]

  • 4. [Anti-aldosterone therapy in severe heart failure].
    van Guldener C, Donker AJ.
    Ned Tijdschr Geneeskd; 1999 Aug 21; 143(34):1724-6. PubMed ID: 10494316
    [Abstract] [Full Text] [Related]

  • 5. Adoption of spironolactone therapy for older patients with heart failure and left ventricular systolic dysfunction in the United States, 1998-2001.
    Masoudi FA, Gross CP, Wang Y, Rathore SS, Havranek EP, Foody JM, Krumholz HM.
    Circulation; 2005 Jul 05; 112(1):39-47. PubMed ID: 15983243
    [Abstract] [Full Text] [Related]

  • 6. Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure.
    Dieterich HA, Wendt C, Saborowski F.
    Fiziol Cheloveka; 2005 Jul 05; 31(6):97-105. PubMed ID: 16366159
    [Abstract] [Full Text] [Related]

  • 7. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study.
    Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, Redelmeier DA.
    N Engl J Med; 2004 Aug 05; 351(6):543-51. PubMed ID: 15295047
    [Abstract] [Full Text] [Related]

  • 8. Usefulness of spironolactone in a specialized heart failure clinic.
    Sligl W, McAlister FA, Ezekowitz J, Armstrong PW.
    Am J Cardiol; 2004 Aug 15; 94(4):443-7. PubMed ID: 15325926
    [Abstract] [Full Text] [Related]

  • 9. Appropriateness of spironolactone prescribing in heart failure patients: a population-based study.
    Ko DT, Juurlink DN, Mamdani MM, You JJ, Wang JT, Donovan LR, Tu JV.
    J Card Fail; 2006 Apr 15; 12(3):205-10. PubMed ID: 16624686
    [Abstract] [Full Text] [Related]

  • 10. Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure.
    Masoudi FA, Havranek EP, Wolfe P, Gross CP, Rathore SS, Steiner JF, Ordin DL, Krumholz HM.
    Am Heart J; 2003 Aug 15; 146(2):250-7. PubMed ID: 12891192
    [Abstract] [Full Text] [Related]

  • 11. Adherence to guidelines for patients hospitalized with heart failure: a nationwide survey.
    Jotkowitz AB, Porath A, Shotan A, Mittelman M, Grossman E, Zimlichman R, Lewis BS, Caspi A, Gottlieb S, Garty M, Steering Committee of the Israel Heart Failure National Survey 2003.
    Isr Med Assoc J; 2006 Dec 15; 8(12):875-9. PubMed ID: 17214110
    [Abstract] [Full Text] [Related]

  • 12. Eplerenone: new drug. Recent myocardial infarction with heart failure: a spironolactone me too.
    Prescrire Int; 2006 Apr 15; 15(82):46-9. PubMed ID: 16604728
    [Abstract] [Full Text] [Related]

  • 13. [Tolerability and efficacy of aldosterone inhibition with canrenone in heart failure: the real-world experience of an outpatient heart failure clinic].
    Nassiacos D, Meloni S.
    Ital Heart J; 2005 May 15; 6 Suppl 1():51S-65S. PubMed ID: 15945300
    [Abstract] [Full Text] [Related]

  • 14. High prevalence of microalbuminuria in chronic heart failure patients.
    van de Wal RM, Asselbergs FW, Plokker HW, Smilde TD, Lok D, van Veldhuisen DJ, van Gilst WH, Voors AA.
    J Card Fail; 2005 Oct 15; 11(8):602-6. PubMed ID: 16230263
    [Abstract] [Full Text] [Related]

  • 15. [Effect of aldosterone antagonism in heart failure: pharmacotherapeutic options].
    Diercks GF, Overdiek JW, van Veldhuisen DJ.
    Ned Tijdschr Geneeskd; 2001 Feb 03; 145(5):204-8. PubMed ID: 11219145
    [Abstract] [Full Text] [Related]

  • 16. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
    van de Wal RM, Plokker HW, Lok DJ, Boomsma F, van der Horst FA, van Veldhuisen DJ, van Gilst WH, Voors AA.
    Int J Cardiol; 2006 Jan 26; 106(3):367-72. PubMed ID: 16337046
    [Abstract] [Full Text] [Related]

  • 17. Association of blood pressure and its evolving changes with the survival of patients with heart failure.
    Grigorian-Shamagian L, Gonzalez-JuAnatey JR, Vazquez R, Cinca J, Bayes-Genis A, Pascual D, Fernandez-Palomeque C, Bardaji A, Almendral J, Nieto V, Macaya C, Jimenez RP, de Luna AB, Muerte Subita En La Insuficiencia Cardiaca (MUSIC) Group.
    J Card Fail; 2008 Sep 26; 14(7):561-8. PubMed ID: 18722321
    [Abstract] [Full Text] [Related]

  • 18. Lack of efficacy of low-dose spironolactone as adjunct treatment to conventional congestive heart failure treatment in dogs.
    Schuller S, Van Israël N, Vanbelle S, Clercx C, McEntee K.
    J Vet Pharmacol Ther; 2011 Aug 26; 34(4):322-31. PubMed ID: 20950346
    [Abstract] [Full Text] [Related]

  • 19. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct 26; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 20. [The aldosterone antagonist spironolactone prolongs the survival of chronic heart failure patients. The results of the RALES study. The Randomized Aldactone Evaluation Study].
    Schwinger RH.
    Dtsch Med Wochenschr; 1999 Aug 27; 124(34-35):987-8. PubMed ID: 10488324
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.